Our mission is to push the boundaries of research to support wellness in those living with neurodegenerative diseases, particularly Parkinson's disease. We are committed to advancing understanding and treatment options, driven by a vision of improving the quality of life for patients. We actively seek creative and passionate scientists to join us in this noble pursuit— we aim to make a lasting impact on the future of neuroscience and contribute to advancement in this vital field.
Methodology
The Simon lab uses a combination of traditional and novel laboratory techniques to test compounds for potential neuroprotective abilities in mice models of Parkinson's disease. Frequently used techniques include cell and tissue culture for in vitro studies, stereotaxic surgery and injection, protein analyses and quantification, and more. Check out our current projects to learn more about our protocols.
Lab Protocol
Our members are trained and certified to utilize advanced laboratory techniques. We work with BIDMC, the Institutional Animal Care and Use Committee (IACUC), and the Collaborative Institutional Training Initiative (CITI) to ensure that lab members know the most up-to-date laboratory safety practices. Please visit the main BIDMC web page to learn more about policies and practices.
Education
Members attend regular lab meetings and seminars, journal clubs, and other events such as annual BIDMC research retreats. Additionally, we often attend and present at national conferences such as the Society for Neuroscience (SfN) Annual Meeting. Additionally, members regularly attend joint lab meetings that spur collaboration and future projects.
Outreach
Part of our mission is to broaden the areas of interest we include in Parkinson's Disease research. The Simon Lab continues to expand its network by collaborating with various institutions. We are happy to recruit new members and push the advancement of Parkinson's research.
Our Collaborators
USP30 as a potential therapeutic target in Parkinson's disease
Multi-omics approaches to Parkinson's disease